Michelle Van Geldermalsen
Camperdown, NSW 2006, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correction: Overexpression of VIRMA confers vulnerability to breast cancers via the m6A-dependent regulation of unfolded protein response.
Journal: Cellular and molecular life sciences : CMLS
Published: July 14, 2023
Overexpression of VIRMA confers vulnerability to breast cancers via the m6A-dependent regulation of unfolded protein response.
Journal: Cellular and molecular life sciences : CMLS
Published: February 06, 2023
Glutamine addiction promotes glucose oxidation in triple-negative breast cancer.
Journal: Oncogene
Published: February 16, 2022
Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth.
Journal: The Journal of pathology
Published: October 19, 2020
Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells.
Journal: The Journal of biological chemistry
Published: October 21, 2018
RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes.
Journal: International journal of cancer
Published: June 14, 2018
SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 20, 2018
Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.
Journal: BMC cancer
Published: February 27, 2018
ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma.
Journal: Oncogenesis
Published: November 20, 2016
Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration.
Journal: Cancer & metabolism
Published: November 12, 2016
Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment.
Journal: Nature communications
Published: September 06, 2016
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
Journal: International journal of cancer
Published: December 09, 2015
Last Updated: 09/26/2026